Oregon 2025R1 Session Status: In Committee Bipartisan · 7 R · 2 D cosponsors

HB 3817 — Directs the Oregon Health Authority and the Department of Veterans' Affairs to study the consumption of ibogaine by certain individuals for the purpose of treating specified disorders.

Last action — In House Committee

  1. ✓
    Introduced
  2. 2
    In Committee
  3. 3
    Passed House
  4. 4
    Passed Senate
  5. 5
    To Executive
  6. 6
    Enacted

This bill is in committee in the House. Introduced April 16, 2025. It must pass committee before a floor vote.

Next likely step: a committee vote, then a floor vote in the House.

Odds of enactment

Low chance

Based on the sponsor, cosponsors, and committee posture, this bill has a low chance of becoming law.

Upgrade to see the exact probability and what's driving it.

A statistical estimate from our own model of past outcomes — an insight, not a guarantee. Policymaking is volatile.

Prognosis

Likely to advance 62% · high confidence
  • In Committee

    Current position in the legislative process.

  • 9 sponsors

    2 primary, 7 co-sponsors signed on.

  • Bipartisan support

    Sponsored across 2 parties (7 R · 2 D) — cross-party backing.

  • Cleared a recorded vote

    Passed 1 recorded vote so far.

Based on stage, sponsorship breadth, committee status, recorded votes, and cross-state momentum — a description of the observable signals, not a prediction.

Summary

<b>Digest: The Act tells OHA and DVA to study the use of ibogaine by some people to help treat certain disorders. (Flesch Readability Score: 68.0).</b> [<i>Digest: The Act tells OHA and DVA to set up a process to let a person with a certain disorder use ibogaine to help treat the disorder. (Flesch Readability Score: 63.3).</i>] Directs the Oregon Health Authority [<i>in collaboration with</i>]<b> and</b> the Department of Veterans' Affairs to [<i>establish a process through which a certain individual may consume ibogaine for a specified purpose</i>]<b> study the consumption of ibogaine by certain individuals for the purpose of treating specified disorders</b>. Defines "ibogaine." Requires the authority and the department to submit a report to the interim committees of the Legislative Assembly related to health care [<i>and veterans</i>] not later than September 15, 2029. [<i>Exempts ibogaine, when obtained and consumed through the established process, from the definition of "controlled substance."</i>] Sunsets on January 2, 2030.

Bill Text

We don't have the full text on file for this bill yet.

Read HB 3817 on the official Oregon source →

Action History

  1. In House Committee

Sponsors

Sponsorship breakdown

Export CSV (upgrade) →

2 sponsors · 7 co-sponsors · 81 not signed on

Sponsors (2)

Co-sponsors (7)

Not signed on (81)

81 members have not signed on to this bill.

Show all 81 →

"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.

Whip count is in markup. Polling the chamber and every recorded vote this session. Only the first open is slow. It’s instant for you after this. Calling the roll · Tallying · Engrossing

Votes

Subjects

Cross-referencing the record. Reading this bill against every other bill in the corpus by meaning, not keywords. Only the first open is slow. It’s instant for you after this. Matching · Ranking · Engrossing

Frequently asked questions

What does HB 3817 do?
<b>Digest: The Act tells OHA and DVA to study the use of ibogaine by some people to help treat certain disorders. (Flesch Readability Score: 68.0).</b> [<i>Digest: The Act tells OHA and DVA to set up a process to let a person with a certain disorder use ibogaine to help treat the disorder. (Flesch Readability Score: 63.3).</i>] Directs the Oregon Health Authority [<i>in collaboration with</i>]<b> and</b> the Department of Veterans' Affairs to [<i>establish a process through which a certain individual may consume ibogaine for a specified purpose</i>]<b> study the consumption of ibogaine by certain individuals for the purpose of treating specified disorders</b>. Defines "ibogaine." Requires the authority and the department to submit a report to the interim committees of the Legislative Assembly related to health care [<i>and veterans</i>] not later than September 15, 2029. [<i>Exempts ibogaine, when obtained and consumed through the established process, from the definition of "controlled substance."</i>] Sunsets on January 2, 2030.
Who sponsors HB 3817?
HB 3817 is sponsored by Alek Skarlatos (Republican), David Brock Smith (Republican), Willy Chotzen (Democrat), Rick Lewis (Republican), John Lively (Democrat), Bruce Starr (Republican), Kim Thatcher (Republican), Darin Harbick (Republican), and E. Werner Reschke (Republican).
What is the current status of HB 3817?
This bill is in committee in the House. Introduced April 16, 2025. It must pass committee before a floor vote.
Where can I track HB 3817?
Track HB 3817 free on One Click Politics — get push/email alerts when it moves.

Make your voice heard on HB 3817

Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.

Stay ahead of HB 3817

Last checked for changes 3 months ago · updated continuously

One Click Politics tracks every bill in Congress and all 50 states.

Track this bill →